FREE U.S. SHIPPING ON ORDER $49+
$130.00
This product requires a telemedicine appointment which we offer for free through our telemedicine partner My Doctror's Live. After you complete your purchase, we will reach out to you about scheduling a quick 5 minute telemedicine appointment. To learn more about My Doctor's Live, please visit My Doctor's Live | Totality Skincare (totality-skincare.com). If after the purchase is made it is determined that you are not eligible for this product, we will cancel your order and issue a full refund.
Use this deep-penetrating, powerful medical-strength facial cream alone or as part of the complete Nu-Derm regimen. Its 4% hydroquinone formula eliminates and prevents age spots, dark spots, hyper-pigmentation, uneven skin tone, and discoloration. Regular application of this pigment-correcting product can help rebuild melanin in the skin, providing a more luminous and unified skin tone.
Obagi Nu-Derm Clear penetrates deep into the third layer of the skin for lasting and effective treatment. It’s safe for daily use and ideal for all skin types.
Effective 4% hydroquinone that helps correct hyperpigmentation, such as dark spots, sun spots, age spots, melasma, and other types of discoloration, for a healthier-looking, more even skin tone.*
This product requires a telemedicine appointment which we offer for free through our telemedicine partner My Doctror's Live. After you complete your purchase, we will reach out to you about scheduling a quick 5 minute telemedicine appointment. To learn more about My Doctor's Live, please visit My Doctor's Live | Totality Skincare (totality-skincare.com). If after the purchase is made it is determined that you are not eligible for this product, we will cancel your order and issue a full refund.
Active Ingredient:
4% Hydroquinone
Warnings and Precautions
Avoid eye and mouth area when applying the product. Do not eat the product.
CONTRAINDICATIONS:
People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.
WARNINGS:
Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.
Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.
Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.
PRECAUTIONS (ALSO SEE WARNINGS):
Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.
Pregnancy Category C: Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated.
Nursing Mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.
Pediatric Usage: Safety and effectiveness in children below the age of 12 years have not been established.
Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted.
*Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.
We use cookies on our website to give you the very best shopping experience we can. By using this site, you agree to its use of cookies.